Glutathione (GSH) is the most abundant low-molecular-weight thiol in mammalian cells and the reference compound for the entire field of cellular redox biochemistry. Supplier catalogs list it as "glutathione peptide" or "L-glutathione peptide," and it is often filed alongside synthetic research peptides even though it is an endogenous tripeptide synthesized in every nucleated cell. This review summarizes its structure, biosynthesis, redox cycling, and the principal research domains in which it has been studied, and it addresses the handling and analytical questions that recur in laboratory work with the lyophilized material. All content is provided strictly for research reference.

What is glutathione peptide? Glutathione is a tripeptide of glutamate, cysteine, and glycine (γ-L-glutamyl-L-cysteinyl-glycine, C10H17N3O6S, 307.3 g/mol) with an unusual γ-peptide bond between glutamate and cysteine. The "L-glutathione peptide" sold for research is the reduced form (GSH), which cycles with its disulfide (GSSG) to buffer cellular redox state and detoxify electrophiles. It is supplied for laboratory research reference only, not for human or veterinary use.

By Peptide Insider Research Team · 11 min read · Last updated September 4, 2026

On this page

Introduction

Few molecules appear in as many branches of the biomedical literature as glutathione. First characterized in detail by Meister and colleagues, whose 1983 review remains the foundational reference for its chemistry and enzymology, GSH has since been implicated in antioxidant defense, xenobiotic conjugation, cysteine storage and transport, protein thiol regulation, and the control of cell death programs [1,2,3]. The compound is present at millimolar concentrations in most cells — typically 1 to 10 mM — which makes it one of the most concentrated non-protein metabolites in the cytosol [1,4].

Because glutathione is a genuine peptide with a defined amino-acid sequence, it is catalogued by research suppliers alongside synthetic signaling peptides such as GHK-Cu, another tripeptide, and mitochondria-directed agents such as SS-31 (elamipretide). Mechanistically, however, it belongs to a different category: rather than acting on a receptor, glutathione is a substrate and cofactor for a family of enzymes that together form the cell's thiol redox buffer. This review treats the compound as a laboratory reference material and does not address any use outside of research.

Biological background: the thiol redox buffer

Aerobic metabolism continuously generates reactive oxygen species (ROS) — superoxide, hydrogen peroxide, and lipid peroxides — as by-products of mitochondrial electron transport and of enzymes such as NADPH oxidases. Cells counter this flux with layered antioxidant systems, and the glutathione system is the highest-capacity of these by mass [4,5]. The central reaction is the oxidation of two GSH molecules to one glutathione disulfide (GSSG), catalyzed by glutathione peroxidases (GPx) as they reduce peroxides to water or alcohols. GSSG is then recycled back to GSH by glutathione reductase (GR) at the expense of NADPH, which is ultimately supplied by the pentose phosphate pathway [1,4].

The ratio of GSH to GSSG — normally greater than 100:1 in healthy cytosol — has been widely used as an index of cellular redox state, and shifts toward GSSG have been reported across models of oxidative stress, aging, and disease [4,6]. Beyond peroxide scavenging, GSH is the co-substrate for glutathione S-transferases (GSTs), which conjugate it to electrophilic xenobiotics and endogenous metabolites to render them water-soluble for export, and it serves as a reservoir and transport form for cysteine, an amino acid that is toxic and readily autoxidized in its free form [1,2,7].

Glutathione is also compartmentalized. Although it is synthesized only in the cytosol, distinct pools exist in mitochondria, the nucleus, and the endoplasmic reticulum. The mitochondrial pool — roughly 10 to 15 percent of the total — is imported through anion carriers and has been reported to be a key determinant of cell survival under oxidative and apoptotic challenge [5]. In the brain, astrocytes have been reported to supply precursors that neurons use to sustain their own GSH synthesis, a metabolic division of labor reviewed in detail by Dringen [8].

Structure, biosynthesis and mechanism of action

Structure. Glutathione is γ-L-glutamyl-L-cysteinyl-glycine. The glutamate residue is linked to cysteine through its side-chain γ-carboxyl group rather than the α-carboxyl, producing a γ-peptide bond that ordinary cellular peptidases do not recognize. This unusual linkage is the reason GSH is stable against intracellular proteolysis and is degraded only by the ectoenzyme γ-glutamyl transpeptidase (GGT) on the outer surface of cells [1,3]. The reactive centre of the molecule is the cysteine thiol (–SH), whose relatively low pKa and nucleophilicity underlie every redox and conjugation function of the compound.

Biosynthesis. GSH is assembled in two ATP-dependent steps. Glutamate-cysteine ligase (GCL, formerly γ-glutamylcysteine synthetase) joins glutamate and cysteine to form γ-glutamylcysteine; glutathione synthetase (GS) then adds glycine [2,3]. GCL is the rate-limiting enzyme and is itself feedback-inhibited by GSH. It is a heterodimer of a catalytic subunit (GCLC) and a modifier subunit (GCLM), and transcription of both is induced by the Nrf2 transcription factor in response to oxidative and electrophilic stress [2,3,7]. Cysteine availability is the second principal constraint on synthesis; cysteine is derived from dietary intake or from methionine via the transsulfuration pathway, and cell-culture work has consistently reported that cystine or cysteine supply limits GSH output [2,3].

Redox cycling. Once formed, GSH participates in the GPx/GR cycle described above. Reported enzyme kinetics indicate that GR maintains the pool almost entirely in the reduced state as long as NADPH is available, which is why a falling GSH:GSSG ratio is interpreted as evidence that peroxide generation has outpaced reductive capacity [4,6].

Protein S-glutathionylation. A growing literature describes GSH not only as an antioxidant but as a signaling molecule. Under oxidative conditions, GSH forms mixed disulfides with cysteine residues on target proteins — a reversible post-translational modification termed S-glutathionylation. Dalle-Donne and colleagues reviewed evidence that this modification protects protein thiols from irreversible over-oxidation and modulates the activity of enzymes, transcription factors, and cytoskeletal proteins across species [9]. Deglutathionylation is catalyzed principally by glutaredoxins, making the modification a controlled redox switch rather than a passive by-product.

Cell death regulation. Depletion of GSH, including its active efflux from the cell, has been reported as an early event in several apoptotic pathways, and Franco and Cidlowski argued that this efflux participates in the execution of apoptosis rather than merely reflecting oxidative damage [10]. Together these findings position glutathione at the intersection of antioxidant defense, detoxification, and signaling.

Evidence by research domain

The glutathione literature spans basic enzymology, cell biology, animal models, and human observational and interventional studies. The table summarizes the principal research domains and the maturity of the evidence in each.

Research domainTypical modelsReported findingsEvidence maturity
Redox enzymologyPurified enzymes, cell lysatesGPx/GR cycling; GST-mediated conjugation; GCL as rate-limiting, Nrf2-inducible step [1,2,3,4]Well established
Mitochondrial biologyIsolated mitochondria, hepatocyte and neuronal culturesMitochondrial GSH pool imported via carriers; depletion associated with sensitization to apoptosis and necrosis [5]Well established (preclinical)
Redox signalingIn vitro biochemistry, cell linesReversible protein S-glutathionylation regulating enzyme, transcription-factor and cytoskeletal function [9]Established, mechanistically active
NeurochemistryAstrocyte–neuron co-cultures, rodent brainAstrocytic supply of GSH precursors to neurons; regional GSH differences [8]Established (preclinical)
Aging and redox statusHuman observational cohorts; precursor-supplementation studiesLower erythrocyte GSH and higher oxidative markers in older adults, associated with reduced synthesis; precursor (cysteine + glycine) provision associated with restored GSH synthesis rates [11]Moderate (small human studies)
Oral bioavailabilityHuman pharmacokinetic and randomized trialsEarly report of no detectable plasma rise after oral GSH [12]; later RCTs reported modest increases in blood GSH stores over months [13] or no change in oxidative-stress biomarkers over 4 weeks [14]Conflicting
Melanogenesis (in vitro)Melanocyte cultures; dermatology reviewsReported in vitro tyrosinase interference and pheomelanin shift; clinical evidence characterized as limited and inconsistent [15]Preliminary / contested

Redox enzymology and detoxification

The enzymology of glutathione is among the best-characterized areas in biochemistry. The reactions catalyzed by GCL, GS, GPx, GR, GST, and GGT have been described in structural and kinetic detail, and reviews by Meister, Lu, Forman, and Griffith collectively document the regulation of the pathway at the level of enzyme expression, substrate supply, and feedback inhibition [1,2,3,4,7]. This body of work provides the mechanistic framework against which every other glutathione finding is interpreted.

Mitochondrial glutathione

Marí and colleagues reviewed evidence that the mitochondrial GSH pool, although a minority of the cellular total, is disproportionately important for cell survival. Depletion of mitochondrial GSH in hepatocyte and neuronal models has been associated with sensitization to tumor-necrosis-factor- and oxidant-induced cell death, and the pool's dependence on carrier-mediated import means it can be selectively compromised even when cytosolic GSH is preserved [5]. This literature connects glutathione research with the broader mitochondrial-peptide field represented on this site by MOTS-c and SS-31.

Human studies of glutathione status and oral supplementation

Human research on glutathione has produced a more mixed picture than the preclinical enzymology. Sekhar and colleagues reported that older adults had lower erythrocyte GSH concentrations and reduced fractional synthesis rates compared with younger adults, and that two weeks of dietary cysteine and glycine provision was associated with restoration of synthesis rates and GSH concentrations in that small cohort [11]. Regarding direct oral glutathione, Witschi and colleagues reported in 1992 that a single large oral dose produced no significant increase in plasma glutathione, cysteine, or glutamate, and concluded that systemic availability of intact oral GSH was negligible in that design [12]. A later six-month randomized controlled trial by Richie and colleagues reported dose-dependent increases in GSH in blood and buccal cells [13], while a separate four-week randomized trial reported no changes in oxidative-stress biomarkers [14]. These studies used different durations, matrices, and endpoints, and the field has not resolved the discrepancy. They are cited here to characterize the state of the literature, not to support any application.

Reduced vs. oxidized glutathione and related thiols

Research catalogs list several glutathione-related materials, and the distinctions matter for experimental design.

MaterialChemical identityResearch relevance
L-Glutathione reduced (GSH)γ-Glu-Cys-Gly with free thiolThe biologically active reductant; the form referred to as "glutathione peptide" in catalogs; oxidizes readily in solution [1,16]
Glutathione disulfide (GSSG)Two GSH linked by a disulfide bondOxidized product of GPx reactions; substrate for GR; used as a reference standard in redox assays [4,16]
S-Acetyl-glutathioneThiol-acetylated GSH derivativeStudied as a more oxidation-stable derivative in cell-culture work; deacetylated intracellularly
N-Acetylcysteine (NAC)Acetylated cysteine (not a peptide)Cysteine precursor used experimentally to raise GSH synthesis rather than supply GSH directly [2,7]
γ-GlutamylcysteineDipeptide intermediateProduct of GCL; bypasses the rate-limiting step in synthesis studies [3]

A frequent point of confusion is the term "glutathione peptides" in the plural, which in catalog usage generally refers to GSH and GSSG together or to GSH plus its acetylated derivative. In the scientific literature the word almost always denotes the reduced tripeptide unless GSSG is specified.

Handling, stability and analytical measurement

Because glutathione is a thiol, its principal laboratory liability is autoxidation. In neutral or alkaline aqueous solution, and in the presence of trace transition metals or dissolved oxygen, GSH progressively converts to GSSG; the reaction is accelerated by heat and light and is slowed at acidic pH and low temperature [16]. Analytical reviews therefore recommend that the lyophilized solid be stored cold, protected from moisture and light, and that solutions be prepared fresh in degassed or acidified buffer and used promptly [4,16]. Reconstituted GSH should not be assumed to remain fully reduced during storage, and any experiment that depends on the GSH:GSSG ratio should verify the redox state of the stock analytically.

Measurement itself is a recognized source of artifact. Giustarini and colleagues documented that GSH can oxidize during sample preparation, spuriously inflating GSSG values, and described a protocol in which the free thiol is immediately alkylated with N-ethylmaleimide (NEM) before deproteinization to lock the redox state at the moment of sampling [16]. Common quantification approaches include the enzymatic recycling assay with DTNB (Ellman's reagent), HPLC with electrochemical or fluorescence detection, and LC–MS/MS; each has trade-offs in specificity and sensitivity that Forman and colleagues review in detail [4]. For research-grade material, certificates of analysis typically report identity by mass spectrometry, purity by HPLC, and residual solvent and water content — parameters that are especially relevant for a hygroscopic thiol.

Lyophilized L-glutathione is offered by research suppliers in vial sizes that commonly range from the hundreds of milligrams to multi-gram quantities, with 1,500 mg vials appearing frequently in catalog listings. These presentations are inventory conventions; they carry no experimental meaning, and this review does not provide reconstitution volumes or concentration protocols, which must be determined by the researcher for the specific assay and validated analytically.

Limitations and research considerations

  • Endogenous abundance confounds exogenous studies. Because cells already contain millimolar GSH, experiments that add exogenous glutathione must account for the fact that intact GSH crosses most plasma membranes poorly and is largely degraded by GGT to its constituent amino acids before re-synthesis inside the cell [1,3,12]. Observed effects in culture may reflect cysteine delivery rather than uptake of the intact tripeptide.
  • Conflicting human bioavailability data. The oral studies summarized above reached different conclusions using different designs [12,13,14]. No consensus exists, and the discrepancy is itself an active research question.
  • Analytical artifact. Reported GSH:GSSG ratios vary by orders of magnitude across studies, in part because of sample-handling oxidation [16]. Comparisons between studies that used different derivatization and detection methods should be made cautiously.
  • Model dependence. Much of the mechanistic literature derives from hepatocytes, erythrocytes, and neuronal cultures; the relative importance of individual glutathione pools and enzymes differs substantially by tissue [5,8].
  • Cosmetic-oriented literature. A portion of the published glutathione literature concerns melanogenesis. Systematic assessment of that literature has characterized the human evidence as limited and inconsistent, and in vitro findings should not be extrapolated [15].
  • Regulatory status. Material sold as "glutathione peptide" for research is designated research use only. Nothing in this review constitutes guidance for any other use.

Where to source for research

For a thiol that oxidizes readily, documentation of purity, water content, and lot traceability is central to reproducible work. Laboratories evaluating L-glutathione for in vitro or preclinical research typically compare suppliers on certificate-of-analysis transparency and third-party analytical testing. Among suppliers in the research space, Short Chain Aminos publishes analytical documentation for its research catalog, while BioPep, Catalyst Research, and Apex Research Services similarly position their materials for laboratory research use. Researchers should independently verify purity data, confirm that the reduced form is specified when GSH is required, and confirm that any material is designated strictly for research use. For a structured framework, see our guide to evaluating research peptide suppliers.

Frequently asked research questions

Is glutathione actually a peptide?

Yes. Glutathione is a tripeptide of glutamate, cysteine, and glycine, but its glutamate is joined through an unusual γ-carboxyl linkage. That γ-peptide bond makes it resistant to ordinary peptidases, so it is degraded only by γ-glutamyl transpeptidase on the cell surface [1,3].

What is the difference between L-glutathione peptide and glutathione disulfide?

L-glutathione, or GSH, is the reduced form with a free cysteine thiol and is the active reductant in cells. Glutathione disulfide, GSSG, is two GSH molecules joined by a disulfide bond after oxidation. Glutathione reductase converts GSSG back to GSH using NADPH [1,4].

Why is the GSH:GSSG ratio used in research?

Healthy cytosol maintains a ratio above 100:1 in favor of GSH. A shift toward GSSG indicates that peroxide production has exceeded reductive capacity, so the ratio is widely used as an index of oxidative stress in cell and tissue studies, subject to careful sample handling [4,6,16].

What limits glutathione synthesis in cells?

Two factors dominate: the activity of glutamate-cysteine ligase, the rate-limiting and feedback-inhibited enzyme induced by Nrf2, and the availability of cysteine. Cell-culture research has consistently reported that cysteine or cystine supply constrains GSH output [2,3,7].

Why does reconstituted glutathione need careful handling?

The cysteine thiol autoxidizes in aqueous solution, particularly at neutral-to-alkaline pH, at room temperature, and in the presence of trace metals, converting GSH to GSSG. Analytical guidance recommends fresh preparation, cold storage, and verification of redox state before use [4,16].

Does oral glutathione raise blood glutathione in research studies?

Results conflict. A 1992 pharmacokinetic study reported no plasma increase after a single oral dose, a six-month randomized trial reported increased blood GSH, and a four-week randomized trial reported no biomarker changes. The discrepancy remains unresolved in the literature [12,13,14].

What is protein S-glutathionylation?

It is a reversible modification in which glutathione forms a mixed disulfide with a cysteine residue on a protein. Research indicates it protects thiols from irreversible oxidation and regulates enzymes and transcription factors, with glutaredoxins reversing the modification [9].

Is glutathione approved for any use?

Glutathione has regulatory status that varies by jurisdiction and product form, but the lyophilized material discussed here is supplied strictly for laboratory research. This review provides no dosing information and is not intended for human or veterinary use.

Works cited

  1. Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711-760. doi:10.1146/annurev.bi.52.070183.003431. PMID: 6137189.
  2. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med. 2009;30(1-2):42-59. doi:10.1016/j.mam.2008.05.005. PMID: 18601945.
  3. Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830(5):3143-3153. doi:10.1016/j.bbagen.2012.09.008. PMID: 22995213.
  4. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1-2):1-12. doi:10.1016/j.mam.2008.08.006. PMID: 18796312.
  5. Marí M, Morales A, Colell A, García-Ruiz C, Fernández-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal. 2009;11(11):2685-2700. doi:10.1089/ARS.2009.2695. PMID: 19558212.
  6. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009;390(3):191-214. doi:10.1515/BC.2009.033. PMID: 19166318.
  7. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med. 1999;27(9-10):922-935. doi:10.1016/s0891-5849(99)00176-8. PMID: 10569625.
  8. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol. 2000;62(6):649-671. doi:10.1016/s0301-0082(99)00060-x. PMID: 10880854.
  9. Dalle-Donne I, Rossi R, Colombo G, Giustarini D, Milzani A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci. 2009;34(2):85-96. doi:10.1016/j.tibs.2008.11.002. PMID: 19135374.
  10. Franco R, Cidlowski JA. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ. 2009;16(10):1303-1314. doi:10.1038/cdd.2009.107. PMID: 19662025.
  11. Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011;94(3):847-853. doi:10.3945/ajcn.110.003483. PMID: 21795440.
  12. Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992;43(6):667-669. doi:10.1007/BF02284971. PMID: 1362956.
  13. Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263. doi:10.1007/s00394-014-0706-z. PMID: 24791752.
  14. Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. 2011;17(9):827-833. doi:10.1089/acm.2010.0716. PMID: 21875351.
  15. Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. 2016;82(3):262-272. doi:10.4103/0378-6323.179088. PMID: 27088927.
  16. Giustarini D, Dalle-Donne I, Milzani A, Fanti P, Rossi R. Analysis of GSH and GSSG after derivatization with N-ethylmaleimide. Nat Protoc. 2013;8(9):1660-1669. doi:10.1038/nprot.2013.095. PMID: 23928499.
  17. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med. 1999;27(9-10):916-921. doi:10.1016/s0891-5849(99)00177-x. PMID: 10569624.

Research Use Only. All content is provided strictly for research reference and is not intended to diagnose, treat, or prevent any condition. Nothing herein constitutes medical advice or guidance for human or veterinary use, and no dosing or reconstitution protocols are provided.

Explore related compounds: SS-31 (elamipretide) · MOTS-c · GHK-Cu · 5-Amino-1MQ